Tag
Regulatory Approval
3 articles
Aurobindo Pharma Q4FY26 Revenue Rises 5.6% to ₹8,853 Cr
Aurobindo Pharma reported Q4FY26 revenue of ₹8,853 crore, a 5.6% YoY growth, driven by a 30.2% surge in Europe formulations.
EBITDA was stable at ₹1,801 crore with a 20.3% margin, while PAT grew 2.0%
Lupin Receives Tentative FDA Approval for Revefenacin
Lupin received tentative FDA approval for generic Revefenacin Inhalation Solution, 175 mcg/3 mL unit-dose vials.
The product is bioequivalent to Mylan's Yupelri® for COPD maintenance treatment with $2
Beta Drugs Gains Regulatory Approvals in Azerbaijan, Philippines
Beta Drugs Limited's manufacturing facility received GMP inspection from Azerbaijan's Ministry of Health, with approval expected within 1-2 months.
The company obtained Certificates of Product Registr